1. Home
  2. RXRX vs PCT Comparison

RXRX vs PCT Comparison

Compare RXRX & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • PCT
  • Stock Information
  • Founded
  • RXRX 2013
  • PCT 2015
  • Country
  • RXRX United States
  • PCT United States
  • Employees
  • RXRX N/A
  • PCT N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • PCT Environmental Services
  • Sector
  • RXRX Health Care
  • PCT Utilities
  • Exchange
  • RXRX Nasdaq
  • PCT Nasdaq
  • Market Cap
  • RXRX 2.0B
  • PCT 1.1B
  • IPO Year
  • RXRX 2021
  • PCT N/A
  • Fundamental
  • Price
  • RXRX $5.11
  • PCT $13.96
  • Analyst Decision
  • RXRX Buy
  • PCT Strong Buy
  • Analyst Count
  • RXRX 5
  • PCT 4
  • Target Price
  • RXRX $7.00
  • PCT $13.00
  • AVG Volume (30 Days)
  • RXRX 32.0M
  • PCT 4.4M
  • Earning Date
  • RXRX 08-07-2025
  • PCT 08-07-2025
  • Dividend Yield
  • RXRX N/A
  • PCT N/A
  • EPS Growth
  • RXRX N/A
  • PCT N/A
  • EPS
  • RXRX N/A
  • PCT N/A
  • Revenue
  • RXRX $59,790,000.00
  • PCT $1,580,000.00
  • Revenue This Year
  • RXRX $23.51
  • PCT N/A
  • Revenue Next Year
  • RXRX $53.87
  • PCT $26.46
  • P/E Ratio
  • RXRX N/A
  • PCT N/A
  • Revenue Growth
  • RXRX 29.32
  • PCT N/A
  • 52 Week Low
  • RXRX $3.79
  • PCT $4.50
  • 52 Week High
  • RXRX $12.36
  • PCT $15.58
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 50.95
  • PCT 70.95
  • Support Level
  • RXRX $4.96
  • PCT $13.54
  • Resistance Level
  • RXRX $5.36
  • PCT $14.23
  • Average True Range (ATR)
  • RXRX 0.41
  • PCT 0.83
  • MACD
  • RXRX 0.02
  • PCT 0.07
  • Stochastic Oscillator
  • RXRX 22.96
  • PCT 67.90

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: